Bristol-Myers Squibb Company
看空

Bristol-Myers Squibb - 10% downside potential

565
When I see a stock go from 2.6 times sales to 6.4 times sales while revenues have fallen from $21 billion to $16 billion, you can tell that investors are hoping for something big coming down the road.

For now, I'll look for a trip down to the lower end of the rising regression channel.

Risk - $64 or $65. Target $53-$54.

Tim 4:25PM EST Feb 27, 2015

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。